NK T-Cell Lymphoma

Also known as: T/NK-Cell Lymphoma / NK/T-cell Lymphoma / NK/T Cell Lymphoma / T-NK Cell Lymphoma / Extranodal NK/T-cell lymphoma, nasal type / Angiocentric lymphoma NOS / Angiocentric lymphoma / Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type / Extranodal natural killer/T-cell lymphoma, nasal type (disorder) / Angiocentric lymphomas / Mature T/NK-cell lymphomas, unspecified / NK/T-cell lymphoma, nasal and nasal-type (morphologic abnormality)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00023Asparaginase Escherichia coli1Withdrawn1
DB00515Cisplatin1Withdrawn1
DB00531Cyclophosphamide1Completed1
DB01234Dexamethasone1Withdrawn1
DB00997Doxorubicin1Completed1
DB00773Etoposide1Completed1
DB00441Gemcitabine1Withdrawn1
DB09035Nivolumab1Withdrawn1
DB00635Prednisone1Completed1
DB00073Rituximab1Completed1
DB06371Siplizumab1Completed1
DB00541Vincristine1Completed1
DB00958Carboplatin1 / 2Recruiting1
DB00773Etoposide1 / 2Recruiting1
DB00441Gemcitabine1 / 2Recruiting1
DB01181Ifosfamide1 / 2Recruiting1
DB00526Oxaliplatin1 / 2Recruiting1
DB14922Tislelizumab1 / 2Recruiting1
DB00928Azacitidine2Not Yet Recruiting1
DB08870Brentuximab vedotin2Recruiting1
DB14776Camrelizumab2Unknown Status1
DB01234Dexamethasone2Not Yet Recruiting1
DB00059Pegaspargase2Not Yet Recruiting1
DB09037Pembrolizumab2Completed1
DB14765Rivoceranib2Unknown Status1
DB14922Tislelizumab2Not Yet Recruiting1
DB01234Dexamethasone4Recruiting1
DB00773Etoposide4Recruiting1
DB00773Etoposide4Unknown Status2
DB00441Gemcitabine4Recruiting1
DB00480Lenalidomide4Unknown Status1
DB00059Pegaspargase4Recruiting1
DB12257Platinum4Recruiting1
DB08877Ruxolitinib4Recruiting1
DB06334Tucidinostat4Unknown Status2